




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Angiography</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=0cff9a6b-fc84-483b-890b-4b2da15dc2d5</link>
        <description>Clinical Topic Feed: Angiography</description>
        <language>en</language>

        

                <item>
                    <title>IVUS-CHIP and OPTIMAL: IVUS-Guided vs. Angiography-Guided PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-combo-acc-2026</link>                    <description>When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.</description>
                    <pubdate>1774885860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DKCRUSH VIII: IVUS-Guided PCI Superior to Angiography-Guided PCI in Complex Coronary Lesions</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-dkcrush-acc-2026</link>                    <description>When using the two-stent double-kissing (DK) crush technique for PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated with a greater reduction in target vessel failure compared to angiography-guided PCI, according to the DKCRUSH VIII trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JACC.</description>
                    <pubdate>1774885560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALL-RISE: AI-Supported Coronary Flow Assessment Performs Similarly to Gold-Standard Wire-Based Testing</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-allrise-acc-2026</link>                    <description>FFRangio, a minimally invasive, artificial intelligence (AI)-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with coronary artery disease (CAD) undergoing assessment for PCI, according to results from the ALL-RISE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in NEJM.</description>
                    <pubdate>1774791240000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CHIP-BCIS3: LV Unloading Not Beneficial During PCI in Patients With Severe LV Dysfunction</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-chip-bcis3-acc-2026</link>                    <description>Among patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes and carried a greater risk of all-cause and cardiovascular mortality...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For Revascularization</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026</link>                    <description>Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>COACT 5 Year Data: Similar Survival With Immediate vs. Delayed Coronary Angiography in OHCA Survivors</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/11/18/58/COACT-5</link>                    <description>At five years, survival was comparable between immediate and delayed angiography with no clinical benefit or harm in patients without ST-segment elevation resuscitated from out-of-hospital cardiac arrest (OHCA), according to new results from the randomized COACT trial published Feb. 4 in JACC.</description>
                    <pubdate>1770840780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Substantial Hospital-Level Variation in Immediate Coronary Angiography Among Patients With STEMI and OHCA | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/11/18/58/Substantial-Hospital-Level-Variation-in-Immediate-Coronary-Angiography-Among-Patients-With-STEMI-and-OHCA-NCDR-Study</link>                    <description>Among patients presenting with both out-of-hospital cardiac arrest (OHCA) and STEMI, substantial hospital-level variation was found in providing immediate coronary angiography (CA), according to a Brief Report published Feb. 11 in JACC.</description>
                    <pubdate>1770836700000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Can Patient-Specific Registration of Jeopardized and Viable Segments Guide Revascularization?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/01/22/18/26/Can-Patient-Specific-Registration</link>                    <description>Patient-specific registration of segmental jeopardy and viability is a feasible strategy to identify patients with ischemic cardiomyopathy (ICM) who benefit from early revascularization, according to a recent study published in JACC: Cardiovascular Imaging.</description>
                    <pubdate>1769454840000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New PAD Performance and Quality Measures Released</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/01/07/14/20/New-PAD-Performance-and-Quality-Measures-Released</link>                    <description>New 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease (PAD), released in collaboration with nine other specialty societies, offer a comprehensive framework to assess and elevate PAD care across clinical settings.</description>
                    <pubdate>1767898800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New in Clinical Guidance | Key Points From the 2025 Advanced Training Statement on Advanced CV Imaging</title>
<link>/Latest-in-Cardiology/Articles/2025/12/01/01/New-in-Clinical-Guidance-Key-Points</link>                    <description>The following are key points from the 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee...</description>
                    <pubdate>1765225800000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>